High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation? | Zendy

Agathe Delbove | Zendy; Ambroise Foubert | Zendy; François Mateos | Zendy; Tiphaine Guy | Zendy; Marie Gousseff | Zendy

Open Access

High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation?

Author(s) -

Agathe Delbove,

Ambroise Foubert,

François Mateos,

Tiphaine Guy,

Marie Gousseff

Publication year - 2021

Publication title -

therapeutic advances in respiratory disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.022

H-Index - 37

eISSN - 1753-4666

pISSN - 1753-4658

DOI - 10.1177/17534666211019555

Subject(s) - medicine , nasal cannula , anesthesia , ards , intubation , fraction of inspired oxygen , hypoxemia , respiratory distress , intensive care unit , interquartile range , continuous positive airway pressure , intensive care medicine , surgery , mechanical ventilation , lung , cannula , obstructive sleep apnea

Backgrounds: High flow nasal cannula (HFNC) is an alternative therapy for acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19). This study aimed first to describe outcomes of patients suffering from COVID-19-related ARDS treated with HFNC; secondly to evaluate safety of HFNC (patients and healthcare workers) and compare patients according to respiratory outcome.Methods: A retrospective cohort was conducted in French general hospital intensive care unit (ICU). Patients were included if receiving HFNC for hypoxemia (saturation pulse oxygen (SpO 2 ) 35/min could be regarded as a predictor of intubation. The reviews of this paper are available via the supplemental material section.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research